Trials / Sponsors / Shanghai EpimAb Biotherapeutics Co., Ltd.
Shanghai EpimAb Biotherapeutics Co., Ltd.
Industry · 8 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Phase I/II Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of the EMB-07 Combination Th Combination Therapy, Aggressive B-Cell Non-Hodgkin Lymphoma, EMB07 | Phase 1 / Phase 2 | 2026-03-01 |
| Recruiting | Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients Metastatic Colorectal Cancer | Phase 2 | 2025-12-18 |
| Unknown | EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer Metastatic Lung Non-Small Cell Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 1 / Phase 2 | 2023-06-01 |
| Unknown | A Study of EMB-09 in Participants With Advanced or Metastatic Solid Tumors. Advanced Solid Tumor | Phase 1 | 2022-07-25 |
| Recruiting | EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers Neoplasms, Neoplasm Metastasis, Metastatic Gastrointestinal Carcinoid Tumor | Phase 1 / Phase 2 | 2021-10-21 |
| Terminated | A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma Relapsed or Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2021-05-20 |
| Terminated | A Study of EMB-02 in Participants With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2021-03-11 |
| Unknown | A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors Neoplasms, Neoplasm Metastasis, Non-Small-Cell Lung Cancer | Phase 1 / Phase 2 | 2018-12-13 |